Nanotechnology Now - Press Release: Applied Nanoscience Issues Progress Report

Home > Press > Applied Nanoscience Issues Progress Report

Abstract:
Applied Nanoscience Inc. (ANI) (PINKSHEETS: APNN) today issued the following progress report:

Applied Nanoscience Issues Progress Report

CARLSBAD, CA | Posted on March 6th, 2008

Testing of filter samples incorporating the company's proprietary silver nanoparticle formulation were tested after a simulated one-year aging process and proved to be highly effective in eradicating avian influenza. An independent BSL-3 laboratory reported a 3.6 log reduction (equivalent to a 99.96% reduction) in the avian influenza simulant H9N2 when exposed to the one-year aged nanoparticle enhanced filter media.

The technology, which has been under development for the past several years, has demonstrated effectiveness against a broad range of other pathogens, such as Staphylococcus aureus, Streptococcus pneumoniae, and the drug resistant S. aureus MRSA.

"We are very encouraged at the sustained progress made with our Nanoparticle - Enhanced - Filtration - Technology platform. The continued focus of our scientific team to include recent scale-up success has put us in a position to begin targeting license partners in a number of consumer markets," said Thomas Allen, President and CEO, ANI.

On February 8, 2008 Applied Nanoscience filed a Form 10-SB under Section 12(g) of The Securities Exchange Act of 1934 to become a fully reporting company. Filing this document one of the necessary steps the company must take to advance to the OTC Bulletin Board (OTCBB). An eventual listing on the OTCBB is expected to enhance the company's profile in public equity markets and make it easier to attract financing.

####

About Applied Nanoscience Inc.
Applied Nanoscience Inc. is a marketer and developer of innovative, high-performance filtration products, systems and technologies to customers worldwide in a focused effort to provide a safer tomorrow.

For more information, please click here

Contacts:
Philippe Niemetz
PAN Consultants Ltd.
800-477-7570
or
212-344-6464

Investor Relations

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: